heshamahli

EYPT Eyepoint Pharmaceuticals Inc buy opportunity Inc

Long
NASDAQ:EYPT   EyePoint Pharmaceuticals, Inc
Buy from 5,6-5,8 with a stop loss of 3,5 and a target of and possibly 47.